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Background: Ethephon (EP) is the most famous plant growth regulator with different adverse effects on
kidney function. Virgin Olive Oil (VOO) is considered as a natural source of antioxidant with beneficial
effects. Thus, this study was conducted to investigate the effects of VOO on nephrotoxicity induced by EP
in rats.
Methods and materials: In this study, 80 male rats (weighing 200e250 g) were divided into four groups
including I: control group received normal saline as vehicle, II: received VOO, III: received EP (150mg/kg/
day) for 2 months, IV: received EP (150mg/kg/day for 2 months, after 2-month pretreatment with VOO.
VOO (2mL/kg/day) and vehicle were administered by gastric gavage for 2 months. At the end, the ani-
mals were sacrificed, and their blood and kidneys were used for examinations. Isolated kidneys were
used for histopathological and oxidative stress studies.
Results: Significant increases were recorded in blood (neutrophils, monocytes) and urinary parameters
as well as malondialdehyde (MDA) content in the group III compared to groups II and I (P˂0.05). Anti-
oxidant enzymes significantly declined and histopathological alterations increased in the group III. In the
group IV, significant decreases were recorded in blood and urinary parameters, MDA, and histopatho-
logical alterations and a significant increase were found in antioxidant enzymes compared to group III
(P˂0.05).
Conclusions: Findings of the present study demonstrated protective effects of VOO in prevention of
kidneys against EP -induced toxicity in albino rats.
© 2019 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Extensive use of pesticides leads to renal toxicity in human and
experimental animals. Pesticides have been reported as main cause
of 27% of acute kidney diseases in the United States.1,2 Pesticides
killing insects such as carbonates and organophosphates are known
to induce nephrotoxicity.3 In recent decades, using chemicals such
as Plant Growth Regulators (PGRs) in agriculture has beenhtari).
for Food and Biomolecules,
National Taiwan University. Produc
es/by-nc-nd/4.0/).associated with many health hazards. Ethephon (EP, 2-chloroethyl
phosphonic acid) is the most famous example of plant growth
regulators used for artificial ripening through release of ethylene,
directly influencing several physiological processes such as
ripening andmaturation. It is used on some crops including cereals,
vegetables, fruits, and crops seeds producing oil.4
Mechanism of action of EP is through release of ethylene fol-
lowed by being absorbed by the plant and interfering in growth
process,and is also used in acceleration of ripening of fruits and
vegetables.5 Previous studies showed that, when EP is administered
orally, it causes various types of disease including necrotic hepatitis
gastroenteritis, and respiratory diseases, in both rats and mice.6,7
Other side effects related to EP administration include ation and hosting by Elsevier Taiwan LLC. This is an open access article under the CC
List of abbreviations:
EP ethephon
VOO Virgin olive oil
PGRs plant growth regulators
MUFA monounsaturated fatty acids
UA Uric acid
Cr Creatinine
BUN blood urea nitrogen
RBCs red blood cells








PCNA proliferating cell nuclear antigen
H&E hematoxylin & eosin
TRI Masson's trichrome
PAS Periodic Acid Schiff
IHC immunohistochemical
DAB 3,3-diaminobenzidine tetrahydrochloride solution
Table 1
Mean values of analytical parameters, fatty acids composition (%)














Total polyphenols (mg/kg) 561.3
Chlorophylls (mg/kg) 11.9
b-Carotene (mg/kg) 7.31
a- tocopherol (mg/kg) 480.79
Data are expressed as mean values. MUFA: monounsaturated fatty
acid; SFA: saturated fatty acids; PUFA: polyunsaturated fatty acid.
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nephritis, glomerulonephritis, mineralization of brain, fibrosis of
heart, etc.8,9 EP also produces hematological changes and inhibits
activity of plasma cholinesterase in intoxicated animals.10 Also, EP
has been shown to induce gonadal disorders,and its teratogenic
effects have been demonstrated in mice.11,12 EP has been reported
to reduce concentrations of DNA and RNA and induce mutagenic
effects.13 Additionally, increased oxidative stress and immunotox-
icity of EP have been demonstrated in the recent studies.14
The use of medicinal herbs and natural compounds has been
proven in treatment and prevention of diseases.15e18 Antioxidant
activities of herbal medicines are effective in reducing toxicities
related to toxic agents and different synthetic drugs.19,20 Global
consumption of Virgin Olive Oil (VOO) known as a Mediterranean
Diet has been significantly increased in the last few decades.21
Consumption of VOO has been suggested to protect individuals
against cardiovascular diseases,22 different types of cancer,23
obesity, type II diabetes, and metabolic syndrome.24 Moreover,
beneficial effects of VOO have been noticed in healthy individuals.25
Two main compositions of VOO are fatty acid and phenolic anti-
oxidants.25 VOO contains a wide variety of antioxidants such as
vitamin E, oleocanthal, carotenoids,and polyphenols like hydrox-
ytyrosol, hydroxytyrosol acetate,and oleuropein, among which
oleuropein especially prevents oxidation of Low-Density Lipopro-
tein (LDL) particles.26,27 Monounsaturated Fatty Acids (MUFA)
especially oleic acid with beneficial effects on cardiovascular sys-
tem constitutes 70e80% of total fatty acids of olive oil.28 Recently,
researchers have focused on preventive effects of phenols with
natural sources against degenerative diseases mediated by Reactive
Oxygen Species (ROS).29,30 Polyphenols of VOO are characterized
for their anti-inflammatory features, applied by down-regulation of
inflammatory mediators through transcriptional or post-
transcriptional mechanisms.31 Hepatoprotective effects of
VOO32,33 and its ameliorative effects on nephrotoxicity induced by
different agents have been demonstrated so that, nephrotoxicity
was ameliorated in animals as a result of administrating VOO or
olive leaf extract.34e36
Therefore, the present study was carried out to investigate the
potential protective effects of VOO on some hematological pa-
rameters and nephrotoxicity induced by sub-chronic administra-
tion of EP in male albino rats.
2. Materials and methods
2.1. Chemicals and drugs
Ethrel, in commercial form containing 48% EP (2-chloroethyl
phosphonic acid) was purchased from Chema Industries. Virgin
Olive Oil (VOO) was purchased from local market and was analyzedin laboratory in Taif University, Taif, Saudi Arabia (analytical pa-
rameters including fatty acids, oxidative stability, and antioxidant
composition are demonstrated in Table 1). VOO contained 68.23% of
monounsaturates (mainly oleic acid), 16.29% of saturates (palmitic
and stearic acids), and 14.21% of polyunsaturated fatty acid. Urea,
Uric Acid (UA), Creatinine (Cr) and Blood Urea Nitrogen (BUN) kits
were purchased from Biovision Inc., (USA). Other chemicals were
purchased from Sigma Company (St. Louis, MO, USA).2.2. Animals
This study was approved by the Ethics Committee of Animal
Experiments at Taif University, Taif, Saudi Arabia,and was per-
formed according to the Guide for the Care and Use of Laboratory
Animals (8th edition, National Academies Press). In this study, 80
male rats (weighing200-250 g) were obtained from Taif laboratory,
and were kept under 12h light/12h dark cycle. Rats were housed in
plastic cages with free access to food and water, and they were
acclimated to laboratory conditions.2.3. Experimental design
After acclimatization of the rats for 1 week, the rats were
randomly divided into four groups, and were placed in separate
plastic cages (20 rats for each group) as below:
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normal saline (NS, 0.9% NaCl) as vehicle by oral administration
(gastric gavage) for 2 months; followed by 2-month adminis-
tration of NS in equal volume intraperitoneally (IP).
Group II: Received VOO (2ml/kg/day) for 2 months by oral
administration33;, followed by 2- month administration of NS in
equal volume IP.
Groups III: Received NS (2ml/kg/day) for 2 months as a vehicle
by oral administration, followed by 2-month administration of
EP (150mg/kg/day).37
Groups IV: Received VOO (2ml/kg/day) by oral administration
as a pretreatment for 2 months; followed by 2-month admin-
istration of EP (150mg/kg/day).2.4. Samples collection and tissue samples
At end of 4th month, the rats were anesthetized through ether
inhalation. Two blood samples were collected from each rat using
intracardiac puncture. One sample was left to clot at 37C, and was
centrifuged at 3000 rpm for 15min. Then, the serumwas separated,
and was stored at20C for biochemical analysis. The other onewas
collected in heparinized tubes to determine hematological pa-
rameters. Both kidneys were isolated, and small slices of right
kidney were cut, and were cleaned and washed with normal saline,
and were fixed for histological examination, and the left kidney in
each rat was processed for tissue enzymes.2.5. Hematological studies
The heparinized blood samples were analyzed regarding num-
ber of Red Blood Cells (RBCs), White Blood Cells (WBCs), Hemo-
globin concentration (Hb), Hematocrit (HCT), and differential count
of polymorphs and lymphocytes according to standard methods
using an Animal Blood Counter-ABC vet (Horiba ABX,
France)38,39(38, 39)37,38(38, 39).̊
̊
2.6. Kidney function assay
To assess the kidney function, blood samples were obtained
through intra cardiac puncture from each rat at end of 2 ndmonth,
and were left to clot at 37 C, and were centrifuged at 3000 rpm for
15min. For biochemical study, levels of urea, uric acid, creatinine,
BUN were assessed in serum of control and experimental animals.
Levels of serum ureawere assessed using the methods proposed by
Banday et al.,40 and then levels of serum UA, serum Cr,and BUN
were evaluated using the methods introduced by Caraway,41
Natelson et al.,42 and Owen et al., respectively43.2.7. Oxidative stress assay
Both kidney samples were dissected and put in Petri dishes.
After washing with physiological saline, the right kidney was taken
for histopathological investigations, and the left one was stored at -
80 C until using for oxidative stress assay. Collected tissues were
grinded with liquid nitrogen in a mortar. Then, grinded tissues
(0.5 g) were homogenized in 2mL of 50mM phosphate buffer (pH
7.8) containing 1mM EDTA and 1% PVP. The homogenate was
centrifuged under cooling at 15,000g for 20min, and the super-
natant was stored at80C until using for determination of Catalase
(CAT),44 Glutathione (GSH),45 and Superoxide Dismutase (SOD)46
activities as well as content of Malondialdehyde (MDA).47̊
2.7. Histopathological studies
Samples obtained from each kidney were fixed in 10% buffered
formalin solution for 72 h. Then, tissue processing was performed,
and tissues were embedded in paraffin blocks. Serial sections (3e5
mm) were prepared using microtome. The sections were stained
with Hematoxylin & Eosin (H&E) to study general histological
features, Masson's Trichrome (TRI) stain was used for detecting
collagen fibers (grade of interstitial fibrosis), Periodic Acid Schiff
(PAS) stain was applied to demonstrate mucopolysaccharides.48
Images were taken at 400magnifications using a light micro-
scope (ZEISS, Axiolab) for each type of staining, and all histopath-
ological studies were analyzed using a blind method by the same
histologist.
1.7.1. H&E staining
In H&E staining, tubular lesion was assessed using a grading
scale ranged from 0 to 5,which is expressed as follows: 0:no
damage, 1:unicellular patchy isolated degeneration, 2: less than
25%, 3¼ 25e50%, 4: 50e75%,and 5: more than 75% tubular
degeneration.49,50 In this way, 20 fields from each section were
randomly selected to evaluate (10 sections for each group).
2.7.2. TRI staining
To investigate deposition of tubulointerstitial collagen, 20 fields
were randomly selected in each TRI-stained section (10 sections for
each group). Grade of interstitial fibrosis as a semiquantitative
scorewas defined as follows: 0: no fibrosis, 1: 1e25% fibrosis (mild),
2: 26e50% fibrosis (moderate), and 3: >50% fibrosis (severe).51
2.7.3. PAS staining
PAS staining was used to show tubular injury using a semi-
quantitative score. This score evaluates percentage of tubular
epithelial cells atrophy, tubular dilatation, and thickening of tubular
basement membrane in cortex and corticomedullary junction as
follows: 0: none; 1: 10%; 2: 10e25%; 3: 26e45%; 4: 46e75%; and 5:
>75% of tubules. 20 fields were randomly selected on each slide
section (10 sections for each group).52
2.7.3. Immunohistochemical staining
For immunohistochemical (IHC) localization of Proliferating Cell
Nuclear Antigen (PCNA), paraffin sections of kidney were depar-
affinized and hydrated. Hydrogen peroxide (3% for 5min) was used
for blocking endogenous peroxidase activity. Renal sections were
incubated with PCNA monoclonal antibody (Dako Corporation,
Carpentaria, CA) over night, and were washed with Phosphate-
Buffered Saline (PBS) for 5min. Then, monoclonal antibody was
linked with biotinylated goat anti-mouse IgG antibody (Daco, LASB
Universal Kit) for 30min. After being washed with PBS for 5min,
sections were incubated with peroxidase -conjugated streptavidin
for 30min. A brown colored reaction was developed by exposing
sections to 3,3-diaminobenzidine tetrahydrochloride solution
(DAB) for 5min,and then they were washed in distilled water.
Sections were counter stained with hematoxylin53. To calculate
percentage of PCNA þ cells, number of stained cells, and total
number of cells were counted. For this purpose, 10 fields were
randomly selected from each sections (10 kidney sections from
each animal group) to be studied.
2.9. Statistical analyses
Statistical analysis was conducted using SPSS software version
16.0 (SPSS Inc., Chicago, IL, USA).Results were expressed as
mean± SEM. Comparison of means was performed using one -way
ANOVA and post-hoc Tukey. P-Values of <0.05 were considered
Table 3
Effects of VOO on kidney function parameters in rats with sub-chronic.
Parameters I II III IV
Urea (mg/dl) 32.16± 3.23 32.67± 2.96 75.88 ± 3.1 * 35.27± 1.12#
UA (mg/dl) 5.02± 0.12 5.89± 0.22 9.12 ± 0.32* 5.96± 0.42#
Cr (mg/dl) 1.31± 0.02 1.15± 0.01 3.95 ± 0.12* 1.12± 0.07#
BUN (mg/dl) 18.01± 3.03 18.32± 2.92 29.91 ± 1.24* 19.01± 2.44#
UA: Uric acid/Cr: Creatinine/BUN: Blood urea nitrogen.
N ¼ 6 in each group/Results were expressed as mean ± SEM/*P < 0.05 (significant
difference compared to groups I&II)/#P < 0.05 (significant difference in comparison
with group III)/I: control and received normal distilled water orally, II: received VOO
(2mL/kg). III: received EP (150mg/kg) for 2 months, IV: Received EP, after succes-
sive administration of VOO.
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3. Results
3.1. Effects of VOO on hematological parameters in rats with sub-
chronic EP
As shown in Table 2, there was a significant decrease in the RBC
and total WBC count, hemoglobin levels and lymphocyte percent-
age and a significant increase in the percentage of neutrophils and
monocytes in rats treated with EP (group III) compared to groups II
and I (P˂0.05, Table 2). RBC and total WBC count, hemoglobin levels
and lymphocyte percentage significantly increased and lymphocyte
percentage and significantly decreased in the group IV (treated
with EP and VOO) compared to group III (P˂0.05, Table 2). No sig-
nificant changes were recorded in hematological parameters be-
tween groups II and I.
3.2. Effects of VOO on kidney function parameters in rats with sub-
chronic EP
As depicted in Table 3, a significant increase was recorded in the
levels of serum urea, UA, Cr, and BUN in animals received EP
compared to groups II and I (P˂0.05, Table 3). Animals in the group IV
showed a significant decrease in the levels of serumurea, UA, Cr, and
BUN compared to group III (P˂0.05, Table 3). No significant alteration
was recorded invalues of serumurea, uric acid, Cr, andBUNbetween
animals treated with VOO (II) and the control group (I).
3.3. Effects of VOO on oxidative stress parameters in rats with sub-
chronic EP
As illustrated in Table 4, there was significant decrease in the
SOD, CAT,and GSH levels and a significant increase in the MDA level
in rats treated with EP (group III) compared to groups II and I
(P˂0.05, Table 4). Animals treated with EP and VOO (group IV)
exhibited a significant increase in the SOD, CAT, and GSH levels and
a significant reduction in the MDA level compared to group III
(P˂0.05, Table 4). No significant changes were recorded in values of
SOD, CAT, GSH, and MDA level between groups II and I.
3.4. Effects of VOO on histopathological alterations in rats with sub-
chronic EP
3.4.1. H&E staining
H&E staining and light microscopic examination showed that,Table 2
Effects of VOO on hematological parameters in rats with sub-chronic EP.
Parameters I II III IV
RBCs ( 106/mL) 5.44± 0.55 5.21± 0.22 3.54 ± 0.82 * 5.78± 0.01#
Hb (g/dl) 12.01± 0.23 12.05± 0.44 9.99 ± 0.82* 11.97± 0.56#
HCT(%) 50.99± 0.96 50.01± 0.17 40.97 ± 0.19* 49.95± 0.67#
WBCs( 103/ml) 5.21± 0.14 5.13± 0.17 9.72 ± 0.11* 5.20± 0.87#
Lymphocytes (%) 35.85± 0.57 35.92± 0.01 26.41 ± 0.66* 36.14± 0.40#
Eosinophils (%) 0.01± 0.02 0.02± 0.03 0.03± 0.03 0.01± 0.01
Basophils (%) 0.00± 0.00 0.00± 0.00 0.00± 0.00 0.00± 0.00
Neutrophils (%) 53.85± 0.32 53.89± 0.54 62.42 ± 0.52* 54.40± 0.43#
Monocytes (%) 6.11± 0.21 6.05± 0.44 8.98 ± 0.01* 6.99± 0.01#
RBC: red blood cells/Hb: Hemoglobin/HCT:/WBCs: white blood cells/HCT: hemato-
crit.
N ¼ 6 in each group/Results were expressed as mean ± SEM/*P < 0.05 (significant
difference compared to groups I&II)/#P < 0.05 (significant difference in comparison
with group III)/I: control and received normal distilled water orally, II: received VOO
(2mL/kg). III: received EP (150mg/kg) for 2 months, IV: Received EP, after succes-
sive administration of VOO.the kidney tissue of control group (group I) and VOO group (group
II) has a normal architecture for glomerulus and tubules. Typical
thick cubic epithelium in proximal convoluted tubules and lower
cubic epithelium in distal convoluted tubules were observed. The
tubules were found to have a relatively regular distinct lumen,
glomerular capsule were lined with a flat epithelium (Fig. 1 (a)). In
the rats treated only with EP (group III), most areas of tubular
damages of kidney were seen to range from mild to severe. These
tubular damages appeared as degeneration of epithelia of renal
tubules characterized by mononuclear cells infiltration and vacu-
olation of cytoplasm. Also, some vascular glomeruli were promi-
nently enlarged and tightly filled the Bowman's capsule resulting in
absence of capsular spaces. Moreover, hyperaemia of the kidney
vessels was observed (Fig. 1 (a)). In the group IV, a marked reduc-
tion was recorded in the toxic effect on the kidney as mild hyper-
aemia in the kidney vessels, as well as a decrease in the
degenerative changes in tubular epithelium (Fig. 1 (a)).
As shown in Fig. 1 (a), (b), there was a significant enhancement
in the mean tubular necrosis score of groups III and IV compared to
groups II and I (P˂0.05). Mean tubular necrosis score reduced in the
group IV (treated with EP and VOO) compared to group III (P˂0.05,
Fig. 1(b)). No significant changes were recorded in mean tubular
necrosis score between groups II and I.
3.4.2. TIR staining
Light microscopic examination of the kidney of the control
group (group I) and VOO group (group II) revealed normal distri-
bution of collagen in these groups based on TIR staining. A signif-
icant increase was also found in the distribution of collagen (grade
of interstitial fibrosis) in the kidney of rats treated with EP (group
III) (P˂0.05, Fig. 2(a), (b)). In the kidney tissue of rats treated with EP
in the group IV, a prominent reduction was observed in the toxic
effect of EP on the kidney with nearly normal distribution of
collagen (P˂0.05, Fig. 2(a) and (b)).
3.4.3. PAS staining
Light microscopic observations of the kidney tissue of rats in
groups II and I revealed strong positive PAS reaction in glomeruli,
proximal, and distal convoluted tubules of rats (Fig 3(b)). The kid-
ney tissues of the rats exposed only to EP (group III) showed a
marked reduction in the PAS reaction in glomeruli, proximal, and
distal convoluted tubules of rats (P˂0.05, Fig 3(b)). PAS reaction of
the kidney tissues of the rats exposed to EP and VOO (group IV)
showed a moderate increased intensity of PAS positive reaction in
glomeruli, proximal ,and distal convoluted tubules of the kidney
compared to group III (P˂0.05, Fig 3(b)).
3.4.4. IHC staining
IHC staining revealed a significant enhancement in the per-
centage of PCNAþ cells in groups III and IV compared to groups II
and I (P˂0.05, Fig 4 (a),(b)). Percentage of PCNAþ cells reduced in the
Table 4
Effects of VOO on stress oxidative parameters in rats with sub-chronic EP.
Parameters I II III IV
SOD (mgr/gr protein) 19.98± 0.65 9.33± 0.02 14.14 ± 0.23* 20.08± 0.03#
CAT(U/mg protein) 90.21± 4.20 89.20± 4.98 49.90 ± 7.18* 91.10± 1.05#
GSH (mgr/mg protein) 170.68± 13.93 169.87± 13.13 110.96 ± 34.12* 169.45± 23.67#
MDA (noml/g protein) 38± 0.34 37 ± 0.45 61 ± 0.18* 37 ± 0.71#
SOD: Superoxide Dismutase/CAT: Catalase/GSH: Glutasthione/MDA: Malondialdehyde.
N ¼ 6 in each group/Results were expressed as mean ± SEM/*P < 0.05 (significant difference compared to groups I &II)/#P < 0.05 (significant difference in comparison with
group III)/I: control and received normal distilled water orally, II: received VOO (2mL/kg). III: received EP (150mg/kg) for 2 months, IV: Received EP, after successive
administration of VOO.
Fig. 1. Effects of VOO on tubular changes in rats with sub-chronic EP a) Renal tissue of groups II and I with normal architecture Renal tissue of group III with severe tubular
damages and degeneration of renal tubules with distinct mononuclear cells infiltration Renal tissue of group IV with mild hyperaemia in the kidney vessels and decreased
degenerative changes H&E staining ( 100) b) Effects of VOO on tubular necrosis score in rats with sub-chronic EP aP˂0.05 compared to group I, bP˂0.05 compared to group II, cP˂0.05
compared to group III. I: control group, II: VOO group, III: EP treated group, IV: VOO pretreatment and EP treated group (G) Renal glomeruli, (bc) Glomerular capsule, (cp) capsular
space, (P) proximal convoluted tubules, (D) distal convoluted tubules, (g) Atrophied glomeruli, (h) Intertubular hemorrhage, (v) vaculles, (h) hemorrhage.
Fig. 2. Effects of VOO on collagen distribution in rats with sub-chronic EP a) Renal tissue of groups II and I with normal distribution of collagen Renal tissue of group III with
increased distribution of collagen Renal tissue of group IV with nearly normal distribution of collagen Masson's trichrome staining ( 100). b) Effects of VOO on grade of interstitial
fibrosis in rats with sub-chronic aP˂0.05 compared to group I, bP˂0.05 compared to group II, cP˂0.05 compared to group III I: control group, II:VOO group, III: EP treated group, IV: VOO
pretreatment and EP treated group (G) Renal glomeruli, (bc) Glomerular capsule, (cp) capsular space, (P) proximal convoluted tubules, (D) distal convoluted tubules, (g) Atrophied
glomeruli, (h) Intertubular hemorrhage, (v) vaculles, (h) hemorrhage, (t) Tubular necrosis, (f) Fibrosis.
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Fig 4 (a), (b)). No significant changes were recorded in percentage of
PCNAþ cells between groups II and I.4. Discussion
Plant growth regulators such as EP have been used to improve
Fig. 3. Effects of VOO on collagen distribution and PAS reaction in rats with sub-chronic EP a) Renal tissue of groups II and I with normal distribution of collagen Renal tissue of
group III with increased distribution of collagen Renal tissue of group IV with nearly normal distribution of collagen Masson's trichrome staining ( 100). b) I: Renal tissue of groups
II and I with strong positive PAS reaction in glomeruli, proximal, and distal convoluted tubules Renal tissue of group III with marked reduction in PAS reaction Renal tissue of group
IV with moderate increased intensity of PAS positive reaction PAS staining ( 100) I: control group, II: VOO group, III: EP treated group, IV: VOO pretreatment and EP treated group
(G) Renal glomeruli, (bc) Glomerular capsule, (cp) capsular space, (P) proximal convoluted tubules, (D) distal convoluted tubules, (g) Atrophied glomeruli, (h) Intertubular hem-
orrhage, (v) vaculles, (h) hemorrhage, (t) Tubular necrosis, (f) Fibrosis.
T. Mokhtari et al. / Journal of Traditional and Complementary Medicine 10 (2020) 487e495492quality and yield of crops54, and oral administration of EP has been
found to have toxic effects on different organs such as the kidney7.
So, the present study was designed to investigate the effects of EP
on hematological alterations and also biochemical and histopath-
ological changes of renal tissues of albino rats. In addition, the
protective effects of VOO against EP-induced nephrotoxicity were
studied.
EP induces its toxic effects through different mechanisms. El
Raouf and Girgis (2011) used different doses of EP ((50, 100,and 150
mg/kg bw/day) for 3 weeks in mice and observed that EP reduced
DNA and RNA concentrations of different tissues such as the brain,
liver,and kidney, and also decreased cholinesterase enzyme activ-
ity, protein content, hemoglobin,and body weight of dams and fe-
tuses.12 Also, Wang et al. (2017)55 and Abou-Zeid et al. (2018)4
observed that EP significantly decreased levels of Hb and Hct inFig. 4. Effects of VOO on percentage of PCNA positive cells in rats with sub-chronic a)
group I, bP˂0.05 compared to group II, cP˂0.05 compared to group III I: control group, II: VO
glomeruli, (T) Renal Tubules, (c) PCNA expression.mice. Also, Abou-Zeid et al. (2018) reported that EP decreased
number of peripheral blood lymphocytes due to its toxic effect on
lymphoid organs.4 In parallel with these studies, the present study
revealed that administrated EP influenced hematopoietic parame-
ters and decreased levels of RBC, Hb, Hct, and also total WBC count
and lymphocyte. Additionally, levels of serum urea, uric acid, Cr,
and BUN significantly elevated in EP-treated rats. El-Okazy et al.
(2008) stated that EP elevated levels of serum urea and Cr dose-
dependently in mice.56 Moreover, El Raouf and Girgis (2011)
demonstrated that EP increased levels of serum urea and Cr in
pregnant mice.12
Additionally, EP reduced levels of antioxidant enzymes such as
SOD, CAT, and GSH, while elevated levels of MDA (as lipid peroxi-
dation landmark) in the renal tissue. In agreement with these re-
sults, Wang et al. (2010) evaluated the effects of EP on oxidativeRenal tissue of different groups with anti-PCNA staining ( 100) aP˂0.05 compared to
O group, III: EP treated group, IV: VOO pretreatment and EP treated group (G) Renal
T. Mokhtari et al. / Journal of Traditional and Complementary Medicine 10 (2020) 487e495 493stress in mice. Their results demonstrated that SOD and GSH ac-
tivities significantly reduced and contents of MDA increased in
blood and spleen.So, EP induced oxidative stress in mice.57 In a
similar study, Abou-Zeid et al. (2018) evaluated the protective ef-
fects of green tea on EP-induced oxidative stress and immunotox-
icity in mice, and indicated that EP enhanced level of MDA and
declined SOD, CAT, Glutathione peroxidase (GPx),and GSH activities
in spleen and thymus of mice.58 The elevation in the MDA level as a
marker of lipid peroxidation increases ROS production and subse-
quently disturbs cell membrane function and integrity.
Histopathological results indicated that, the kidney of the rats
treated with EP showed degeneration of epithelia of renal tubules
characterized by mononuclear cells infiltration and tubular cyto-
plasmic vacuolation. Increased tubular necrosis score and
enlargement of vascular glomeruli with increased distribution of
collagen were recorded in EP group. Moreover, PAS positive reac-
tion decreased in glomeruli, proximal, and distal convoluted tu-
bules in EP group. In similar studies, EP caused vacuolation and
degeneration of renal tubular epithelium, interstitial hemor-
rhage,and multifocal mononuclear cells infiltration between the
renal tubules.4 Percentage of PCNA positive epithelial cells
increased in EP group. This increase in the expression of PCNA in
sub-chronic condition may be associated with tissue regeneration
as a repair response. Nakopoulou et al. (1997) demonstrated that
PCNA þ cells were observed in abnormal condition more frequent
than normal kidneys. Furthermore, in glomerulonephritis,
enhanced PCNA expression in tubular epithelial cells may be
correlated with their proposed function and role in the renal injury
progression.59 So, these findings suggest that, EP -induced kidney
dysfunction (elevation of serum urea, uric acid, Cr, and BUN) is
associated with enhanced oxidative stress biomarkers and subse-
quent histopathological alterations in the renal tissue.
Nowadays, there is considerable interest in administration of
natural dietary antioxidants as a tool to suppress oxidative stress
and potential protective and therapeutic agents against free
radicals.60e62
Different studies suggested that herbal medicine and their de-
rivatives can be used in clinic or as preventive treatment to reduce
tissue damages induced by toxic agents through their antioxidant
and anti-inflammatory characteristics.63,64 Olive oil has been
shown to be rich in antioxidant polyphenols with free radical
-scavenging features.65 In this study, VOO was used in a pretreat-
ment program to ameliorate toxic effects of EP on the kidney. VOO
could be effective against EP -induced toxicity by improving he-
matological values and renal function. Also, it was found that
oxidative stress and histopathological alterations reduced in the
group treated with VOO and EP. Histopathological studies revealed
a mild hyperaemia in the kidney vessels, reduced degenerative
alterations in tubular epithelium and cystic dilatation and
decreased distribution of collagen in the group IV. Abdelgayoum
et al. (2015) evaluated the effects of VOO on amikacin-induced
nephrotoxicity in rats and demonstrated that VOO could decline
amikacin-induced nephrotoxicity by improving the kidney function
and tubular necrosis.34 In a parallel investigation, Wani et al. (2018)
stated that administration of extra-VOO reduced cadmium
-induced nephrotoxicity in mice. These therapeutic characteristics
of VOO were applied by improving levels of the kidney function
parameters (blood urea and serum Cr) and antioxidant (SOD,
GPx,and CAT) markers and also histopathological alterations.36
Capasso et al. (2008) proved that hydroxytyrosol (DOPET), a natu-
ral olive oil antioxidant diminished cyclosporine -induced neph-
rotoxicity in rats.66 Necib et al. (2013) reported the reduction of
oxidative stress and improvement of the kidney function in mer-
curic chloride -induced nephrotoxicity in rats.67
Furthermore, antioxidant properties of olive oil have beenpresented in in -vitro studies neutralizing toxic species and even
preventing early stages of their formation.68 In an experimental
study, Khalatbary et al. (2017) showed that VOO consumption
attenuated deltamethrin-induced hepatotoxicity in mice. They
stated that these beneficial effects of VOO might be related to its
anti-oxidative, anti-apoptotic,and anti-inflammatory characteris-
tics.69 Additionally, Ghorbel et al. (2017) stated that VOO abrogated
acrylamide-induced nephropathy through modulation of
biochemical factors (MDA, hydrogen peroxide (H2O2), Protein
Carbonyls (PCOs), glutathione, Non-Protein Thiols (NPSHs), vitamin
C CAT, SOD, GPx, Lactate Dehydrogenase (LDH), Cr, urea, and uric
acid(urinary volume and creatinine clearance levels) and histo-
logical alterations (tubular dilatation, glomeruli fragmentation,
glomeruli Bowman's space enlargement, hemorrhage,and infiltra-
tion of leucocytes) in rats.70
Expression of PCNA increased in the EP group pretreated with
VOO (group IV). These findings suggest that VOO could accelerate
tissue regeneration against EP-induced nephrotoxicity. Adminis-
tration of VOO in a pretreatment program process resulted in a
significant lower number of proliferating cells compared to the EP
group. As VOO accelerated renal regeneration after EP treatment,
the decrease in the PCNA expression may prove the fact that, VOO
promotes cell proliferation until renal histology and morphology is
replaced. PCNA is an auxiliary protein of DNA polymerase d present
in S (synthesis)-phase of cell cycle and plays a critical role in
initiation of cell proliferation.71 PCNA expression is directly corre-
lated with rates of cellular proliferation and DNA synthesis.72,73
Bledsoe et al. (2008) demonstrated that PCNA positive cells
increased in the renal cortex 1 day (acute phase) after gentamicin
treatment as a toxic agent, which reduced 2 weeks later (chronic
phase).74
Conclusion
Results of the present study revealed that administration of EP
could induce nephrotoxicity and kidney dysfunction by increased
oxidative stress and renal tissue necrosis. However, pretreatment
with VOO provided a renoprotective condition against EP through
its antioxidant and free radical scavenging activities. Thus, it can be
concluded that VOO might be considered as a beneficial dietary
supplement for a person who is exposed to EP.
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